Yuan Jing, Liu Zhuoni, Yin Tianxiang, Meng Shengxi
Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai 200233 China
Shanghai Sixth People's Hospital East Affiliated to Shanghai University of Medicine & Health Sciences Shanghai 201306 China.
RSC Adv. 2025 Aug 4;15(34):27652-27660. doi: 10.1039/d5ra03681j. eCollection 2025 Aug 1.
Eutectogels have emerged as promising materials with broad application potential. Herein, therapeutic deep eutectic solvents (THEDESs) based on the active pharmaceutical ingredients oxymatrine and lauric acid were developed. The physical properties, , density, refractive index, surface tension, and viscosity, of the THEDESs were measured. Among these investigated THEDESs, THEDES (3 : 7) has been shown to self-aggregate into a gel in water. The rheological behavior, microscopic structure of the eutectogel, and the gelation mechanism were further explored. Furthermore, THEDES (3 : 7) can enhance the solubility and stability of curcumin effectively. The eutectogel (with and without curcumin) possessed good antioxidant and anti- activity. To summarize, a simple method based on the self-assembly of THEDES in water was proposed to construct a therapeutic eutectogel, which could potentially be extended as a generalized strategy.
低共熔凝胶已成为具有广泛应用潜力的有前景的材料。在此,开发了基于活性药物成分氧化苦参碱和月桂酸的治疗性低共熔溶剂(THEDESs)。测量了THEDESs的物理性质,即密度、折射率、表面张力和粘度。在这些研究的THEDESs中,THEDES(3∶7)已被证明在水中自聚集成凝胶。进一步探索了低共熔凝胶的流变行为、微观结构和凝胶化机制。此外,THEDES(3∶7)可以有效提高姜黄素的溶解度和稳定性。该低共熔凝胶(含和不含姜黄素)具有良好的抗氧化和抗炎活性。总之,提出了一种基于THEDES在水中自组装的简单方法来构建治疗性低共熔凝胶,这有可能作为一种通用策略得到推广。
Drug Dev Ind Pharm. 2024-5
Arch Ital Urol Androl. 2025-6-30
ACS Appl Mater Interfaces. 2025-8-13
Cochrane Database Syst Rev. 2018-2-6
Psychopharmacol Bull. 2024-7-8
Cochrane Database Syst Rev. 2008-7-16
Cochrane Database Syst Rev. 2004
J Med Chem. 2024-9-12
Drug Dev Ind Pharm. 2024-5
Fitoterapia. 2023-7
ACS Pharmacol Transl Sci. 2023-3-6
Chem Rev. 2021-2-10
AAPS PharmSciTech. 2020-10-14
ACS Appl Bio Mater. 2019-10-21